Cargando…
Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease
Pompe disease or glycogen storage disease type II is a rare autosomal recessive disorder caused by a deficiency of the lysosomal enzyme a-glucosidase. Although enzyme replacement therapy (ERT) with 2 weekly intervals following was considered an effective treatment for Pompe disease in 2006, few pati...
Autores principales: | Tang, Shan, Ma, Jiachu, Meng, Huaxing, Guo, Junhong, Cao, Shuyan, Wang, Binquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837892/ https://www.ncbi.nlm.nih.gov/pubmed/33546050 http://dx.doi.org/10.1097/MD.0000000000024276 |
Ejemplares similares
-
Analysis and strategy research on quality of nursing work life
por: Wang, Lei, et al.
Publicado: (2020) -
Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014) -
The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021) -
Effect of total quality management intervention on nurse commitment and nurse performance: A quasi-experimental study
por: Alzoubi, Majdi M., et al.
Publicado: (2023) -
Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Moriggi, Manuela, et al.
Publicado: (2021)